Dim light melatonin onset and circadian temperature during a constant routine in hypersomnic winter depression

Acta Psychiatrica Scandinavica
K DahlP N Prinz

Abstract

The onset of melatonin secretion under dim light conditions (DLMO) and the circadian temperature rhythm during a constant routine were assessed in 6 female controls and 6 female patients with winter depression (seasonal affective disorder, SAD) before and after bright light treatment. After sleep was standardized for 6 days, the subjects were sleep-deprived and at bedrest for 27 h while core temperature and evening melatonin levels were determined. The DLMO of the SAD patients was phase-delayed compared with controls (2310 vs 2138); with bright light treatment, the DLMO advanced (2310 to 2135). The minimum of the fitted rectal temperature rhythm was phase-delayed in the SAD group compared with the controls (0542 vs 0316); with bright light treatment, the minimum advanced (0542 vs 0336).

References

Dec 1, 1978·The Journal of Physiology·J N MillsJ M Waterhouse
Oct 1, 1976·The American Journal of Psychiatry·J S CarmanF K Goodwin
Jan 1, 1990·Biological Psychiatry·N E RosenthalT A Wehr
Jan 1, 1989·Chronobiology International·D S Minors, J M Waterhouse
Jan 1, 1989·Chronobiology International·A J Lewy, R L Sack
Jan 1, 1985·Psychopharmacology·J B Kamien, W L Woolverton
Oct 1, 1988·Metabolism: Clinical and Experimental·D S WeigleJ D Brunzell
Aug 1, 1988·Archives of General Psychiatry·J B Williams
Jan 16, 1987·Science·A J LewyT M Hoban
Jan 1, 1972·Archives of General Psychiatry·J P FeighnerR Munoz
Dec 1, 1967·The British Journal of Social and Clinical Psychology·M Hamilton
Dec 12, 1980·Science·A J LewyS P Markey

❮ Previous
Next ❯

Citations

Dec 16, 2006·Psychopharmacology·Edda PjrekSiegfried Kasper
Dec 7, 2006·European Archives of Psychiatry and Clinical Neuroscience·Edda PjrekSiegfried Kasper
Dec 20, 2013·Journal of Neural Transmission·Tal Ashkenazy-FrolingerNoga Kronfeld-Schor
Aug 1, 1994·Biological Psychiatry·D H AveryA L Kazaras
Mar 1, 1994·Journal of Psychiatric Research·M S BauerJ G Marcus
Nov 13, 2001·Biological Psychiatry·K M KoorengevelS Daan
Aug 22, 2001·Biological Psychiatry·D H AveryP N Prinz
Jan 1, 1996·Pharmacology & Therapeutics·W C Duncan
Feb 13, 2003·Psychiatry Research·Kathelijne M KoorengevelRutger H van den Hoofdakker
Jan 1, 1993·Health Care for Women International·S K ElmoreG L Brengelmann
Feb 1, 1997·Journal of the American Academy of Child and Adolescent Psychiatry·C A GlodY Ito
Aug 4, 2011·Neuropsychobiology·Gerald PailSiegfried Kasper
Sep 9, 2000·Journal of Physiological Anthropology and Applied Human Science·H E Kim, H Tokura
Aug 13, 2011·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·B EtainM Leboyer
Oct 1, 2008·Sleep Medicine·Sarah Laxhmi ChellappaChristian Cajochen
Jul 30, 2008·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Palmiero Monteleone, Mario Maj
Sep 1, 1994·Medical Hypotheses·T Partonen
Feb 25, 2000·Biological Psychiatry·K M KoorengevelR H van den Hoofdakker
Aug 4, 2006·Progress in Neuro-psychopharmacology & Biological Psychiatry·Seithikurippu R Pandi-PerumalLeonid Kayumov
May 17, 2005·Clinics in Sports Medicine·Teodor T Postolache, Dan A Oren
Jan 9, 2014·Chronobiology International·Mark A Oldham, Domenic A Ciraulo
Aug 10, 2010·Progress in Neuro-psychopharmacology & Biological Psychiatry·Palmiero MonteleoneMario Maj
May 12, 2009·Journal of Neuroscience Methods·Laurence M KatzChristopher J Gordon
Aug 4, 2005·Journal of Biological Rhythms·Elizabeth B Klerman
Mar 26, 2003·QJM : Monthly Journal of the Association of Physicians·L Sher
Oct 12, 2002·Journal of Biological Rhythms·Kathelijne M KoorengevelRutger H van den Hoofdakker
Jun 1, 1995·Journal of Biological Rhythms·M TermanS S Campbell
Aug 4, 2018·Clinical & Experimental Optometry : Journal of the Australian Optometrical Association·Lisa A Ostrin
Mar 26, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Mariusz PappElisabeth Mocaër
Jul 25, 2006·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Venkataramanujan SrinivasanDaniel P Cardinali
Jul 13, 2006·Expert Review of Neurotherapeutics·Dietmar WinklerSiegfried Kasper
Oct 20, 2015·Current Psychiatry Reports·Sara DallaspeziaFrancesco Benedetti
May 2, 2003·Chronobiology International·Andres Magnusson, Diane Boivin
Jul 26, 2005·CNS Spectrums·Edda PjrekSiegfried Kasper
Jul 26, 2005·CNS Spectrums·Chang-Ho Sohn, Raymond W Lam
Oct 7, 2000·Chronobiology International·K V DanilenkoM Terman
Mar 4, 2005·CNS Spectrums·P H Desan, D A Oren

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.